Prognostic Factors and Survival Data of Stage I Lung Cancer: A Single-Center Experience
Open Access
- 1 January 2025
- journal article
- Published by Kare Publishing in Journal of Clinical Practice and Research
- Vol. 47 (5) , 519-527
Abstract
Objective: Even in stage I lung cancer, the heightened risk of recurrence may lead to diminished survival rates. Only a few reports on prognostic factors have been published for stage I disease using the most recent staging system. This study was designed to identify predictive factors of recurrence and survival in early-stage lung cancer (LC) staged according to the eighth edition of the Tumor, Node, Metastasis (TNM) classification. Materials and Methods: The clinicopathological characteristics, treatment, and follow-up data of 100 stage I patients monitored between 2013 and 2023 were retrospectively reviewed. The association between clinicopathological factors and survival was analyzed to identify prognostic factors. Results: The median age was 61 years (range, 35–76). All patients had a histologic diagnosis of non-small cell lung cancer, with 62% being adenocarcinoma. During a median follow-up of 40.3 months (range, 1–183.5), 20 patients experienced recurrence and 16 died. The two-year and five-year disease-free survival (DFS) rates were 81% and 73%, respectively, while overall survival (OS) rates for the same periods were 86% and 77%. Multivariate analysis revealed that a smoking history greater than 40 pack-years (p=0.021) and perineural invasion (PNI) (p=0.049) were predictors of recurrence, while the presence of lymphovascular invasion (LVI) was significantly associated with OS (p=0.019). Conclusion: Smoking significantly increases the risk of LC development and recurrence, making it crucial to promote smoking cessation. Patients with positive LVI or PNI in early-stage LC should be monitored more closely, although further research is warranted.Keywords
This publication has 30 references indexed in Scilit:
- Evidence of slight improvement in five-year survival in non-small-cell lung cancer over the last 10 years: Results of the French KBP-CPHG real-world studiesBulletin du Cancer, 2019
- Factors influencing recurrence following anatomic lung resection for clinical stage I non-small cell lung cancerLung Cancer, 2019
- Perineural invasion of cancer: a complex crosstalk between cells and molecules in the perineural niche2019
- Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decadesCancer Management and Research, 2019
- Smoking, alcohol, and nutritional status in relation to one-year mortality in Danish stage I lung cancer patientsLung Cancer, 2018
- Factors associated with distant recurrence following R0 lobectomy for pN0 lung adenocarcinomaThe Journal of Thoracic and Cardiovascular Surgery, 2018
- Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring SurvivalJNCI: Journal of the National Cancer Institute, 2017
- Optimal delivery of follow-up care following pulmonary lobectomy for lung cancerLung Cancer: Targets and Therapy, 2016
- The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung CancerJournal of Thoracic Oncology, 2016
- Performance Status and Smoking Status Are Independent Favorable Prognostic Factors for Survival in Non-small Cell Lung Cancer: A Comprehensive Analysis of 26,957 Patients with NSCLCJournal of Thoracic Oncology, 2010